Circulating Tumor Cell Clinical Trial
Official title:
Zhongnan Hospital of Wuhan University
Through the screening of CTCs in patients with suspected liver cancer and liver tumor resection or liver transplantation, the number of CTCs in the blood of liver cancer patients before and after surgery is monitored, and the clinical application significance of CTCs in liver cancer screening and postoperative recurrence monitoring in liver cancer patients is evaluated.
1. Screen patients with suspected liver cancer Long-term exposure to liver cancer risk factors (hepatitis B carriers, past history of schistosomiasis, long-term diet of Aspergillus food, history of liver cirrhosis, etc.), patients with liver cancer are initially suspected. 2. Monitor the number of CTCs in the blood of patients with liver cancer before and after surgery Imaging examinations show that liver space is occupied by patients with suspected liver cancer. Use CTCBIOPSY® technology to monitor patients' surgical operations (including interventional therapy, tumor resection, or liver cancer liver transplantation) at different times 1-3 days before, 1 month after surgery, and 6 months after surgery The number of CTCs in peripheral blood. 3. To evaluate the clinical application significance of CTCs in liver cancer screening and postoperative recurrence monitoring in patients with liver cancer Combined with clinicopathology, tumor marker examination and imaging examination, clinical follow-up and follow-up, analyze the clinical significance of CTCs detection in liver cancer patients, and focus on evaluating the relationship between circulating tumor cells in liver cancer screening and postoperative recurrence, and establish a new The liver cancer prediction model improves the prognosis of liver cancer patients. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05070637 -
Circulating Tumor Cell Reducing No-touch Nephrectomy
|
N/A | |
| Recruiting |
NCT05360290 -
CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial
|
N/A | |
| Active, not recruiting |
NCT03776591 -
Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer
|
N/A | |
| Completed |
NCT04083547 -
Circulating Tumour Cells in Patients With Peritoneal Metastases
|
||
| Recruiting |
NCT03744962 -
MSI in Circulatory DNA of Endometrial Cancer
|
||
| Not yet recruiting |
NCT05560776 -
Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC
|
N/A | |
| Completed |
NCT05297955 -
Circulating Tumor Cell Detection in Hepatocellular Carcinoma
|
||
| Recruiting |
NCT04601961 -
Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients
|
N/A | |
| Completed |
NCT03960021 -
Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin
|
N/A | |
| Recruiting |
NCT04811846 -
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
|
N/A | |
| Completed |
NCT03479099 -
Liquid Biopsy in Lung Cancer
|
||
| Recruiting |
NCT03979339 -
Feasibility of a New Technology for Isolating Circulating Tumour Cells
|
N/A | |
| Recruiting |
NCT04993014 -
Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT04696744 -
Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)
|
||
| Recruiting |
NCT03071900 -
CTC Detection Rate in SCCHN With a in Vivo Device
|
N/A | |
| Withdrawn |
NCT04280640 -
Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes
|
||
| Recruiting |
NCT05346536 -
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)
|
N/A | |
| Not yet recruiting |
NCT04917276 -
Treatment Response Prediction System of mCRC Patients Based on CTC
|
||
| Not yet recruiting |
NCT04912882 -
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
|
||
| Not yet recruiting |
NCT03958812 -
Diagnostic Power Comparison Between VOCs and CTCs
|